Time to death and mast cell degranulation in fatal asthma

Respirology

Volumn 14, Issue 6, 2009, Pages 808-813

  Elliot, John G ^a   Abramson, Michael J ^b   Drummer, Olaf H ^b   Walters, E Haydn ^c   James, Alan L ^a,d  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Airway wall; Degranulation; Fatal asthma; Mast cell; Smooth muscle

Indexed keywords

SALBUTAMOL; TRYPTASE;

AIRWAY; ARTICLE; ASTHMA; AUSTRALIA; AUTOPSY; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; MORTALITY; PRIORITY JOURNAL; SMOOTH MUSCLE;

ADOLESCENT; ADULT; ASTHMA; AUSTRALIA; CELL DEGRANULATION; CHILD; DEATH; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG; MALE; MAST CELLS; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 69049105462     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01551.x     Document Type: Article

References (24)

1. Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur. Respir. J. 1997 10 : 292 300.
2. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am. Rev. Respir. Dis. 1993 147 : 405 410.
3. Carroll N, Carello S, Cooke C, James A. Airway structure and inflammatory cells in fatal attacks of asthma. Eur. Respir. J. 1996 9 : 709 715.
4. James AL, Elliot JG, Abramson MJ, Walters EH. Time to death, airway wall inflammation and remodelling in fatal asthma. Eur. Respir. J. 2005 26 : 429 434.
5. Carroll NG, Mutavdzic S, James AL. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur. Respir. J. 2002 19 : 879 885.
6. Rivera J, Fierro NA, Olivera A, Suzuki R. New insights on mast cell activation via the high affinity receptor for IgE. Adv. Immunol. 2008 98 : 85 120.
7. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 2006 117 : 1277 1284.
8. Carroll NG, Mutavdzic S, James AL. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 2002 57 : 677 682.
9. Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis. 1993 148 : 713 719.
10. Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffery PK. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am. Rev. Respir. Dis. 1992 145 : 1477 1482.
11. Gieras A, Focke-Tejkl M, Ball T, Verdino P, Hartl A et al. Molecular determinants of allergen-induced effector cell degranulation. J. Allergy Clin. Immunol. 2007 119 : 384 390.
12. Abramson MJ, Bailey MJ, Couper FJ, Driver JS, Drummer OH et al. Are asthma medications and management related to deaths from asthma? Am. J. Respir. Crit. Care Med. 2001 163 : 12 8.
13. Couper FJ, Drummer OH. Gas chromatographic-mass spectrometric determination of beta 2-agonists in postmortem blood: application in forensic medicine. J. Chromatogr. B Biomed. Appl. 1996 685 : 265 272.
14. James AL, Hogg JC, Dunn LA, Pare PD. The use of the internal perimeter to compare airway size and to calculate smooth muscle shortening. Am. Rev. Respir. Dis. 1988 138 : 136 139.
15. James A. Theoretic effects of mucus gland discharge on airway gland resistance in asthma. Chest 1995 107 : 110S.
16. Valenta R, Kraft D. Recombinant allergen molecules: tools to study effector cell activation. Immunol. Rev. 2001 179 : 119 127.
17. Henderson LL, Larson JB, Gleich GJ. Maximal rise in IgE antibody following ragweed pollination season. J. Allergy Clin. Immunol. 1975 55 : 10 15.
18. Oskeritzian CA, Schwartz LB. Human mast cells and bsaophils: heterogeneity and mediators. In: Busse WW, Holgate ST (eds) Asthma And Rhinitis, 2nd edn. Blackwell Science Ltd, Oxford, 2000 275 295.
19. McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 2003 170 : 1625 1629.
20. Nightingale JA, Rogers DF, Barnes PJ. Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma. Am. J. Respir. Crit. Care Med. 1999 159 : 1786 1790.
21. Russo C, Zeng D, Prosperini G, Spicuzza L, Guarino F et al. Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5′ monophosphate nasal challenge. Clin. Exp. Allergy 2005 35 : 1192 1196.
22. Johnson M. The beta-adrenoceptor. Am. J. Respir. Crit. Care Med. 1998 158 : S146 53.
23. Murray CS, Poletti G, Kebadze T, Morris J, Woodcock A et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006 61 : 376 382.
24. Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002 359 : 831 834.